China CDC's SCI papers grow steadily in 2022, JCRTM analysis finds
The number of China CDC's SCI papers increased steadily over the past year, according to analysis done by the center on literature published or co-published by its researchers and were included in the SCIE and SSCI databases for the Web of Science core collection in 2022.
The analysis was conducted based on the 2023 Journal Citation Reports TM (JCRTM), released by Clarivate Analytics on June 28.
The JCRTM has become an important benchmark to evaluate the academic influence of researchers working at the Chinese Center for Disease Control and Prevention (China CDC).
Data show that in 2022, researchers from the China CDC contributed to the publication of 1,540 papers, an increase of 12.99 percent compared with 2021. Among them, 1,336 were articles and 75 reviews, accounting for 91.62 percent.
There are 927 papers whose first author or corresponding author comes from the China CDC, accounting for about 60.2 percent. The journal with the largest number of published papers is China CDC Weekly, with 133.
The top five research directions in terms of publication volume are public affairs, environment and occupational health, environmental science, infectious diseases, microbiology, and immunology, which are consistent with 2021.
The research done by the China CDC staff mainly focuses on four themes, namely the novel coronavirus infection, strain mutation and sequencing, the impact of air pollution on health and disease burden, the risk factors and prevalence of various chronic non-communicable diseases in China, and the regulation of intestinal microbiota and cancer immunotherapy.
According to the analysis, 1,292 of the 1,540 academic papers included in SCI were co-published, 83.9 percent of the total. And some 1,724 institutions have had academic cooperation with the China CDC, the top five of which are Chinese Academy of Sciences, Chinese Academy of Medical Sciences-Peking Union Medical College, Peking University, World Health Organization, and Shanghai Jiaotong University.
There are four English-language journals hosted and organized by the China CDC, namely China CDC Weekly, Biomedical and Environmental Sciences (BES), Infectious Diseases of Poverty (IDP), and Biosafety and Health.
China CDC Weekly, launched in November 2019, has been recognized as China's national public health bulletin. Since publication, it has been included in the three authoritative databases of ESCI, Scopus and PMC of Web of Science. In 2022, it became the only English journal in China to be included in SCIE and SSCI at the same time. It is also the second English journal in the history of Chinese journals to be included in both databases.
In addition, BES and IDP have been included by SCI, while Biosafety and Health has not yet. In JCRTM 2022, the impact factor of IDP is 8.1, and the impact factor of BES is 3.5. China CDC Weekly got the impact factor for the first time, achieving a good score of 4.7.